Valliant John
Chief Executive Officer at Fusion Pharmaceuticals Inc.
- Sold, on record
- $1.6M
- Dollars the filings state
- Form 4 sales
- 16
- Latest Apr 27, 2022
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Fusion Pharmaceuticals Inc.Chief Executive Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Fusion Pharmaceuticals Inc.Plan not statedMar 23, 2022 2022
Sold 4,800 shares at $7.52 ($36k)
Valliant John, Chief Executive Officer
Sold 1.3% of holdings ($2.9M position)377,560 shares left0.3x usual sizeFiling
- 2 Form 4 sale Fusion Pharmaceuticals Inc.Plan not statedMar 29, 2022 +6 days
Sold 10,300 shares at $7.54 ($78k)
Valliant John, Chief Executive Officer
Sold 2.7% of holdings ($2.8M position)367,260 shares left0.7x usual sizeFiling
- 3 Form 4 sale Fusion Pharmaceuticals Inc.Plan not statedMar 30, 2022 +1 day
Sold 300 shares at $7.52 ($2k)
Valliant John, Chief Executive Officer
Sold 0.1% of holdings ($2.8M position)366,960 shares left0x usual sizeFiling
- 4 Form 4 sale Fusion Pharmaceuticals Inc.Plan not statedApr 5, 2022 +6 days
Sold 3,800 shares at $7.72 ($29k)
Valliant John, Chief Executive Officer
Sold 1% of holdings ($2.8M position)363,160 shares left0.4x usual sizeFiling
- 5 Form 4 sale Fusion Pharmaceuticals Inc.Plan not statedApr 8, 2022 +3 days
Sold 2,181 shares at $7.55 ($16k)
Valliant John, Chief Executive Officer
Sold 0.6% of holdings ($2.7M position)360,979 shares left0.3x usual sizeFiling
- 6 Form 4 sale Fusion Pharmaceuticals Inc.UnusualApr 13, 2022 +5 days
Sold 32,849 shares at $6.87 ($226k)
Valliant John, Chief Executive Officer
Sold 9.1% of holdings ($2.5M position)328,130 shares left6.8x usual sizeFiling
- 7 Form 4 sale Fusion Pharmaceuticals Inc.Plan not statedApr 21, 2022 +8 days
Sold 1,289 shares at $6.01 ($8k)
Valliant John, Chief Executive Officer
Sold 0.4% of holdings ($2M position)326,841 shares left0.2x usual sizeFiling
- 8 Form 4 sale Fusion Pharmaceuticals Inc.Plan not statedApr 27, 2022 +6 days
Sold 8,694 shares at $6.04 ($53k)
Valliant John, Chief Executive Officer
Sold 2.7% of holdings ($2M position)318,147 shares left1.8x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (16)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Apr 27, 2022 | Apr 27, 2022 | Fusion Pharmaceuticals Inc. | Chief Executive Officer | Form 4 sale | 8,694 | $53k | 2.7% | Plan not stated | SEC |
| Apr 21, 2022 | Apr 22, 2022 | Fusion Pharmaceuticals Inc. | Chief Executive Officer | Form 4 sale | 1,289 | $8k | 0.4% | Plan not stated | SEC |
| Apr 13, 2022 | Apr 13, 2022 | Fusion Pharmaceuticals Inc. | Chief Executive Officer | Form 4 sale | 32,849 | $226k | 9.1% | Unusual | SEC |
| Apr 8, 2022 | Apr 8, 2022 | Fusion Pharmaceuticals Inc. | Chief Executive Officer | Form 4 sale | 2,181 | $16k | 0.6% | Plan not stated | SEC |
| Apr 5, 2022 | Apr 5, 2022 | Fusion Pharmaceuticals Inc. | Chief Executive Officer | Form 4 sale | 3,800 | $29k | 1.0% | Plan not stated | SEC |
| Mar 30, 2022 | Apr 1, 2022 | Fusion Pharmaceuticals Inc. | Chief Executive Officer | Form 4 sale | 300 | $2k | 0.1% | Plan not stated | SEC |
| Mar 29, 2022 | Mar 29, 2022 | Fusion Pharmaceuticals Inc. | Chief Executive Officer | Form 4 sale | 10,300 | $78k | 2.7% | Plan not stated | SEC |
| Mar 23, 2022 | Mar 24, 2022 | Fusion Pharmaceuticals Inc. | Chief Executive Officer | Form 4 sale | 4,800 | $36k | 1.3% | Plan not stated | SEC |
| Mar 21, 2022 | Mar 21, 2022 | Fusion Pharmaceuticals Inc. | Chief Executive Officer | Form 4 sale | 3,604 | $27k | 0.9% | Plan not stated | SEC |
| Mar 16, 2022 | Mar 16, 2022 | Fusion Pharmaceuticals Inc. | Chief Executive Officer | Form 4 sale | 1,500 | $10k | 0.4% | Plan not stated | SEC |
| Mar 11, 2022 | Mar 14, 2022 | Fusion Pharmaceuticals Inc. | Chief Executive Officer | Form 4 sale | 2,822 | $20k | 0.7% | Plan not stated | SEC |
| Mar 8, 2022 | Mar 8, 2022 | Fusion Pharmaceuticals Inc. | Chief Executive Officer | Form 4 sale | 14,504 | $104k | 3.6% | Plan not stated | SEC |
| Mar 3, 2022 | Mar 3, 2022 | Fusion Pharmaceuticals Inc. | Chief Executive Officer | Form 4 sale | 27,593 | $205k | 6.4% | Plan not stated | SEC |
| Feb 28, 2022 | Feb 28, 2022 | Fusion Pharmaceuticals Inc. | Chief Executive Officer | Form 4 sale | 13,752 | $103k | 3.1% | Plan not stated | SEC |
| Feb 23, 2022 | Feb 23, 2022 | Fusion Pharmaceuticals Inc. | Chief Executive Officer | Form 4 sale | 38,297 | $298k | 7.9% | Plan not stated | SEC |
| Feb 17, 2022 | Feb 17, 2022 | Fusion Pharmaceuticals Inc. | Chief Executive Officer | Form 4 sale | 47,502 | $384k | 8.9% | Plan not stated | SEC |